Literature DB >> 29168843

How T cells spot tumour cells.

Siranush Sarkizova1, Nir Hacohen2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29168843     DOI: 10.1038/d41586-017-07267-9

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade.

Authors:  Lee P Richman; Robert H Vonderheide; Andrew J Rech
Journal:  Cell Syst       Date:  2019-10-09       Impact factor: 10.304

2.  A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens.

Authors:  Daniel M Altmann
Journal:  Immunology       Date:  2018-11       Impact factor: 7.397

3.  Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.

Authors:  Renzo G DiNatale; A Ari Hakimi; Timothy A Chan
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

4.  Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cells.

Authors:  John W Hickey; Ariel Isser; Sebastian F Salathe; Kayla M Gee; Meng-Hsuan Hsiao; Wasamah Shaikh; Nkechi C Uzoukwu; Joan Glick Bieler; Hai-Quan Mao; Jonathan P Schneck
Journal:  Nano Lett       Date:  2020-06-28       Impact factor: 12.262

Review 5.  A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept.

Authors:  Daniel Satgé
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

6.  A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation.

Authors:  Pratik S Bhojnagarwala; Alfredo Perales-Puchalt; Neil Cooch; Niranjan Y Sardesai; David B Weiner
Journal:  Mol Ther Oncolytics       Date:  2021-04-16       Impact factor: 7.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.